Compare Plug Power Inc (PLUG) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Plug Power Inc vs Tango Therapeutics Inc. — how do they compare? Plug Power Inc trades at $1.41 (market cap $2.18B), while Tango Therapeutics Inc. trades at $22.5 (market cap $3.75B). The key difference: Tango Therapeutics Inc. is the larger of the two by market cap, and Tango Therapeutics Inc. is trading nearer its 52-week high, Plug Power Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Plug Power Inc for 42 Days and Tango Therapeutics Inc. for 0 Days on average.
| PLUG | TNGX | |
|---|---|---|
Market Cap | $2.18B | $3.75B |
Volume | 58,569,311 | 9,619,106 |
Sector | Industrials | Health |
52-Week High | $4.14 | $32.90 |
52-Week Low | $1.45 | $7.50 |
Typical Hold Time | 42 Days | 0 Days |
Enterprise Value | $3.05B | $2.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Plug Power (PLUG) trades at $1.56, down 3.7% with a bearish technical outlook. The company shows persistent financial challenges with negative gross margins (-18.55%) and net income margin (-220.59%), though revenue grew to $710M in 2025. Recent news highlights strategic partnerships including a 280 MW electrolyzer agreement with Arcadia eFuels, positioning PLUG in the green hydrogen ecosystem. Cash flow remains negative with -$47M net cash flow in 2025, requiring ongoing financing.
Outlook remains speculative with significant execution risks despite analyst consensus of $2.65 price target (44.7% buy rating). The stock faces substantial operational losses, high cash burn, and competitive pressure in clean energy. Upside depends on successful hydrogen infrastructure deployment and margin improvement, while downside risks include funding challenges and delayed profitability.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
